Evidence map›Paper›PMID 20048137›Full record

ReviewMolecular interventions2009

PHD fingers: epigenetic effectors and potential drug targets.

Catherine A Musselman, Tatiana G Kutateladze

Abstract readReview
In one paragraph

Review in Molecular interventions, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Structure, function, and pathology of PHF23.Frontiers in cell and developmental biology · 2025
    Review
  5. Review
  6. MLL4 binds TET3.Structure (London, England : 1993) · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Non-histone binding functions of PHD fingers.Trends in biochemical sciences · 2023
    Review
  11. Chemical tools targeting readers of lysine methylation.Current opinion in chemical biology · 2023
    Review
  12. Article
  13. KDM4 Demethylases: Structure, Function, and Inhibitors.Advances in experimental medicine and biology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Catherine A MusselmanDepartment of Pharmacology, University of Colorado Denver, Aurora, CO 80045, USA.
Tatiana G Kutateladze

Funding

Membrane Targeting by PI-binding DomainsR01GM071424 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2006 to 2009
$1.0M
Structural basis of signaling by ING2 PHDR01CA113472 · NCI · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2006 to 2010
$987k
NCI NIH HHS CA113472NCI NIH HHS R01 CA113472NIGMS NIH HHS GM071424NIGMS NIH HHS R01 GM071424
6 · The paper itself

Abstract

The plant homeodomain (PHD) finger is found in many chromatin-remodeling proteins. This small approximately 65-residue domain functions as an "effector" that binds specific epigenetic marks on histone tails, recruiting transcription factors and nucleosome-associated complexes to chromatin. Mutations in the PHD finger or deletion of this domain are linked to a number of human diseases, including cancer, mental retardation, and immunodeficiency. PHD finger-containing proteins may become valuable diagnostic markers and targets to prevent and treat these disorders. In this review, we highlight the progress recently made in understanding the functional significance of chromatin targeting by mammalian PHD fingers, detail the molecular mechanisms and structural features of "histone code" recognition, and discuss the therapeutic potential of PHD fingers.

Indexed as

Epigenesis, GeneticGene Expression RegulationGenetic Diseases, InbornGenetic TherapyHumansProteinsProteins

Identifiers

PMID20048137
PMCPMC2861807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.